| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 33 |
| 1 | EVEROLIMUS TABLETS | 26 |
| 2 | PREGABALIN | 24 |
| 3 | ALENDRONATE SODIUM | 22 |
| 4 | CAPECITABINE | 22 |
| 5 | HYDROXYCHLOROQUINE SULFATE | 22 |
| 6 | ALBUTEROL SULFATE | 21 |
| 7 | TELMISARTAN | 21 |
| 8 | TIOTROPIUM BROMIDE | 21 |
| 9 | ADALIMUMAB | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENCICLOVIR | 1 | 0.0028 |
| 1 | METYRAPONE | 2 | 0.0020 |
| 2 | EVEROLIMUS TABLETS | 26 | 0.0015 |
| 3 | LANREOTIDE ACETATE | 12 | 0.0015 |
| 4 | AZATHIOPRINE SODIUM | 3 | 0.0012 |
| 5 | TELMISARTAN | 21 | 0.0011 |
| 6 | GOSERELIN | 13 | 0.0010 |
| 7 | EVEROLIMUS | 33 | 0.0007 |
| 8 | BARICITINIB | 2 | 0.0007 |
| 9 | EXEMESTANE | 13 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 39 |
| 1 | mTOR Inhibitor Immunosuppressant [EPC] | 33 |
| 2 | Corticosteroid [EPC] | 32 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 25 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 22 |
| 6 | Purine Antimetabolite [EPC] | 18 |
| 7 | Interleukin-5 Antagonist [EPC] | 16 |
| 8 | RANK Ligand Inhibitor [EPC] | 14 |
| 9 | Aromatase Inhibitor [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 16 | 0.0233 |
| 1 | Adrenal Steroid Synthesis Inhibitor [EPC] | 2 | 0.0020 |
| 2 | Somatostatin Analog [EPC] | 4 | 0.0006 |
| 3 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 5 | Estrogen Receptor Antagonist [EPC] | 13 | 0.0003 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 7 | Purine Antimetabolite [EPC] | 18 | 0.0002 |
| 8 | Bismuth [EPC] | 1 | 0.0002 |
| 9 | Interleukin-17A Antagonist [EPC] | 6 | 0.0002 |